Harvard Corporation Elects Chenault, Mills

New members of senior governing board succeed Robert D. Reischauer and Robert E. Rubin.

Kenneth I. Chenault, J.D.’76, and Karen Gordon Mills, A.B. ’75, M.B.A. ’77, were elected as Harvard Corporation members. They will begin their service as Fellows of Harvard College on July 1.

The University announced today that Kenneth I. Chenault, J.D. ’76, and Karen Gordon Mills ’75, M.B.A. ’77, have been elected members of the Harvard Corporation, the senior governing board, effective July 1. They succeed retiring members Robert D. Reischauer ’63, who is the senior fellow, and Robert E. Rubin ’60, LL.D. ’01; they will conclude their service at the end of the academic year, as announced last October.

Chenault is chairman and chief executive officer of American Express Company. Mills was administrator of the U.S. Small Business Administration from 2009 to 2013, and is currently a fellow at the Business School and the Harvard Kennedy School.

According to the news announcement, Chenault, a graduate of Bowdoin College, has served on the Harvard Law School visiting committee and is a member of the Committee on University Resources (COUR), Harvard’s most senior fundraising advisory group. His service commitments include the boards or advisory councils of the National Academy Foundation, the NYU Langone Medical Center, the Smithsonian Institution’s National Museum of African American History and Culture, the National September 11 Memorial & Museum at the World Trade Center, and the Bloomberg Family Foundation.  He is also a director of IBM and Procter & Gamble. Kenneth and Kathryn Cassell Chenault’s son Kenneth graduated from the College in 2012; son Kevin is a senior.

Mills, according to the news announcement, has resumed her role as president of a private-equity firm in Maine. She was previously founding partner of a venture-capital firm, and has served on the boards of Scotts Miracle-Gro, Arrow Electronics, Guardian Insurance, Latina Media Ventures, and Annie’s Homegrown. She was earlier a McKinsey & Company consultant and a General Foods product manager. She was a member of the Board of Overseers, the junior governing board, from 1999 to 2005, and a Radcliffe College trustee from 1985 to 1993. Her visiting-committee service includes the business school, engineering and applied sciences, the department of chemistry and chemical biology, and the information-technology operation. She is also a COUR member. She is married to Barry Mills, president of Bowdoin College. They have three sons, including George, a junior at Harvard.

 

Related topics

You might also like

The Faculty of Arts and Sciences Zeroes In on the Classroom Experience

Class schedules and academics are at the top of the agenda for Harvard faculty.

Harvard Football: Harvard 59, Holy Cross 24

Another week, another blowout, this one against an in-state rival

Trump Says a Deal with Harvard Is Close

Administration squeezes Harvard finances, and a federal judge blasts deportation efforts as unconstitutional.

Most popular

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.

Three Harvardians Win Macarthur Fellowships

A mathematician, a political scientist, and an astrophysicist are honored with “genius” grants for their work.

Explore More From Current Issue

Brandon Terry, wearing a blue suit, standing before The Embrace, a large bronze sculpture of intertwined arms in Boston Common.

A New Narrative of Civil Rights

Political philosopher Brandon Terry’s vision of racial progress

Book cover of "Black Moses" by Caleb Gayle with subtitle about ambition and the fight for a Black state.

Civil Rights In the American West

A new book chronicles one man’s quest for a Black state.

Illustration of scientists injecting large syringe with mitochondria into human heart.

Do Mitochondria Hold the Power to Heal?

From Alzheimer’s to cancer, this tiny organelle might expand treatment options.